The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

被引：0
|
作者：
Sahin, Ezgi [1 ]
Yonal-Hindilerden, Ipek [1 ]
Hindilerden, Fehmi [2 ]
Daglar-Aday, Aynur [3 ]
Nalcaci, Meliha [1 ]
机构：
[1] Istanbul Univ, Div Hematol, Dept Internal Med, Istanbul Med Fac, Istanbul, Turkey
[2] Univ Hlth Sci Bakirkoy Dr Sadi Konuk Training & R, Hematol Clin, Istanbul, Turkey
[3] Istanbul Univ, Div Med Genet, Dept Internal Med, Istanbul Med Fac, Istanbul, Turkey
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
JAK2V16F mutation; polycythemia vera; essential thrombocythemia; primary myelofibrosis; MPN;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-364
引用
收藏
页码：S337 / S338
页数：2
相关论文
共 50 条
  • [21] Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
    A M Vannucchi
    E Antonioli
    P Guglielmelli
    A Pardanani
    A Tefferi
    Leukemia, 2008, 22 : 1299 - 1307
  • [22] Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms:: a critical reappraisal
    Vannucchi, A. M.
    Antonioli, E.
    Guglielmelli, P.
    Pardanani, A.
    Tefferi, A.
    LEUKEMIA, 2008, 22 (07) : CP5 - 1307
  • [23] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
    Gango, Ambrus
    Mozes, Reka
    Boha, Zsofia
    Kajtar, Bela
    Timar, Botond
    Kiraly, Peter Attila
    Kiss, Richard
    Fesus, Viktoria
    Nagy, Noemi
    Demeter, Judit
    Korosmezey, Gabor
    Borbenyi, Zita
    Marton, Imelda
    Szoke, Anita
    Masszi, Tamas
    Farkas, Peter
    Varkonyi, Judit
    Plander, Mark
    Posfai, Eva
    Egyed, Miklos
    Pal, Katalin
    Radvanyi, Gaspar
    Hamed, Aryan
    Csomor, Judit
    Matolcsy, Andras
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
  • [24] High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms
    Solli, Camilla Nordheim
    Chamat-Hedemand, Sandra
    Elming, Hanne
    Ngo, Anh
    Kjaer, Lasse
    Skov, Vibe
    Sorensen, Anders Lindholm
    Ellervik, Christina
    Hasselbalch, Hans
    Bruun, Niels Eske
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 400 - 406
  • [25] Is the Absence of JAK2V617F Mutation a Risk Factor for Bleeding in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms?
    Ahmed, Shima A.
    Abdallah, Ghada E. M.
    Aly, Mai M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S357 - S357
  • [26] JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms
    Eickhardt-Dalboge, Christina Schjellerup
    Nielsen, Henrik V.
    Fuursted, Kurt
    Stensvold, Christen Rune
    Andersen, Lee O' Brien
    Lilje, Berit
    Larsen, Morten Kranker
    Kjaer, Lasse
    Christensen, Sarah Friis
    Knudsen, Trine Alma
    Skov, Vibe
    Sorensen, Anders Lindholm
    Ellervik, Christina
    Olsen, Lars Ronn
    Christensen, Jens Jorgen Elmer
    Nielsen, Xiaohui Chen
    Hasselbalch, Hans Carl
    Ingham, Anna Cacilia
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 776 - 787
  • [27] Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice
    Shi, Kaiyao
    Zhao, Wanke
    Chen, Yun
    Ho, Wanting Tina
    Yang, Ping
    Zhao, Zhizhuang Joe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [28] How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?
    Chen, Edwin
    Mullally, Ann
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 268 - 276
  • [29] JAK2-V617F Mutation is Associated with Clinical and Laboratory Features of Myeloproliferative Neoplasms
    Duletic, Antica Nacinovic
    Dekanic, Andrea
    Hadzisejdic, Ita
    Kusen, Ivona
    Matusan-Llijas, Koviljka
    Grohovac, Dragana
    Grahovac, Blazenka
    Jonjic, Nives
    COLLEGIUM ANTROPOLOGICUM, 2012, 36 (03) : 859 - 865
  • [30] Underlying mechanisms of the JAK2V617F mutation in the pathogenesis of myeloproliferative neoplasms
    Mullally, A.
    PATHOLOGE, 2016, 37 : 175 - 179
12345